Market Overview:
The global bioengineered skin substitutes market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of burn injuries and skin diseases, rising awareness about advanced wound care products, and technological advancements in the field of bioengineering. The global bioengineered skin substitutes market is segmented on the basis of type into allogenic, autologous, xenogeneic, acellular, and other types. The allogenic type segment is expected to account for the largest share of the global bioengineered skin substitutes market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to its high adoption rate across hospitals and wound care centers worldwide. On the basis of application, the global bioengineered skin substitutes market is divided into hospitals, specialty clinics, and wound care centers.
Product Definition:
Bioengineered skin substitutes are materials that have been engineered to replace or support the function of skin. They are often used to treat burns, wounds, and other injuries. Bioengineered skin substitutes can help promote healing and reduce the risk of infection.
Allogenic:
Allogenic, it's usage and growth factor in Bioengineered Skin Substitutes market? Allogenic, it's usage and growth factor in the global bio engineered skin substitutes market size, Share & Trends Analysis Report By Product (Formalin Fixed Paraffin Wax Based), By Application (Wound Care), And Segment Forecasts To 2024 -> The global allogenic, its usage and growth factor in the bio engineered skin substitutes market was valued at USD 8.2 billion in 2015.
Autologous:
Autologous is derived from the Greek word auto which means self and logos which means speech. In other words, autologous is a procedure or therapy in which a patient's own cells are used to treat or heal an injury or disease. The most common use of autologous products includes the treatment of burns, ulcers, and skin grafts.
Application Insights:
The wound care centers segment held the largest share of the market in 2017. This is due to increasing cases of chronic wounds and burns across the globe. The chronic wounds comprise diabetic foot ulcers, venous leg ulcers, and others such as pressure ulcers and burn injuries. According to a study published in 2019 by NCBI, it was estimated that around 6% of patients suffer from some form of chronic wound every year globally. In addition, according to WHO, around 15 million people annually suffer from severe burns injuries worldwide making it one of the major causes for disability across all age groups globally.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of bioengineered skin substitutes manufacturers and well-established healthcare infrastructure. Moreover, increasing cases of burn injuries have led to an increase in demand for these products in this region. According to the data published by CDC, around 3 million people suffer from burns annually. In addition, growing awareness about advanced treatment options for various skin diseases is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due its rapidly developing medical tourism industry.
Growth Factors:
- Increasing incidence of skin diseases and disorders: The global prevalence of skin diseases is increasing at an alarming rate. This is primarily due to the changing lifestyles and environmental conditions. According to a study by the World Health Organization (WHO), nearly 3 billion people are affected by some form of skin disease, out of which over 2 million die each year. Bioengineered skin substitutes can be used for treating various types of skin diseases, including burns, chronic wounds, and ulcers.
- Growing demand for advanced wound care products: The global market for advanced wound care products is expected to grow at a CAGR of 7% during the period 2017-2023. Bioengineered skin substitutes are one of the most advanced wound care products available in the market today and their demand is expected to grow rapidly in coming years owing to their superior healing properties.
- Rising awareness about benefits of bioengineeredskin substitutes: There has been a growing awareness among healthcare professionals as well as patients about the benefits offered by bioengineeredskin substitutes over traditional methods such as dressings and bandages for treating various typesof woundsand ulcers .Thisis likelyto boostthe adoption rateof theseproductsin future .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioengineered Skin Substitutes Market Research Report
By Type
Allogenic, Autologous, Xenogeneic, Acellular, Other
By Application
Hospitals, Specialty Clinics, Wound Care Centers
By Companies
Boston Scientific, Smith & Nephew, AbbVie Inc, Stryker Corporation, Anika Therapeutics Inc, Zimmer Biomet Holdings, Vericel Corporation, Integra LifeSciences, Aroa Biosurgery, Organogenesis Inc, Mölnlycke Health Care AB, AlloSource, Cook Biotech Incorporated, Promethean LifeSciences, ACell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Bioengineered Skin Substitutes Market Report Segments:
The global Bioengineered Skin Substitutes market is segmented on the basis of:
Types
Allogenic, Autologous, Xenogeneic, Acellular, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Wound Care Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Smith & Nephew
- AbbVie Inc
- Stryker Corporation
- Anika Therapeutics Inc
- Zimmer Biomet Holdings
- Vericel Corporation
- Integra LifeSciences
- Aroa Biosurgery
- Organogenesis Inc
- Mölnlycke Health Care AB
- AlloSource
- Cook Biotech Incorporated
- Promethean LifeSciences
- ACell
Highlights of The Bioengineered Skin Substitutes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Allogenic
- Autologous
- Xenogeneic
- Acellular
- Other
- By Application:
- Hospitals
- Specialty Clinics
- Wound Care Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioengineered Skin Substitutes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioengineered skin substitutes are artificial skin products that have been designed to imitate the appearance, function, and feel of natural human skin. Bioengineered skin substitutes can be made from a variety of materials, including silicone, polyurethane foam, and plastic. They may be used to cover injuries or defects on the body or as part of cosmetic surgery procedures.
Some of the key players operating in the bioengineered skin substitutes market are Boston Scientific, Smith & Nephew, AbbVie Inc, Stryker Corporation, Anika Therapeutics Inc, Zimmer Biomet Holdings, Vericel Corporation, Integra LifeSciences, Aroa Biosurgery, Organogenesis Inc, M¶lnlycke Health Care AB, AlloSource, Cook Biotech Incorporated, Promethean LifeSciences, ACell.
The bioengineered skin substitutes market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioengineered Skin Substitutes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioengineered Skin Substitutes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioengineered Skin Substitutes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioengineered Skin Substitutes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioengineered Skin Substitutes Market Size & Forecast, 2018-2028
4.5.1 Bioengineered Skin Substitutes Market Size and Y-o-Y Growth
4.5.2 Bioengineered Skin Substitutes Market Absolute $ Opportunity
Chapter 5 Global Bioengineered Skin Substitutes Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bioengineered Skin Substitutes Market Size Forecast by Type
5.2.1 Allogenic
5.2.2 Autologous
5.2.3 Xenogeneic
5.2.4 Acellular
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bioengineered Skin Substitutes Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bioengineered Skin Substitutes Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Wound Care Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioengineered Skin Substitutes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioengineered Skin Substitutes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bioengineered Skin Substitutes Analysis and Forecast
9.1 Introduction
9.2 North America Bioengineered Skin Substitutes Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bioengineered Skin Substitutes Market Size Forecast by Type
9.6.1 Allogenic
9.6.2 Autologous
9.6.3 Xenogeneic
9.6.4 Acellular
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bioengineered Skin Substitutes Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Wound Care Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bioengineered Skin Substitutes Analysis and Forecast
10.1 Introduction
10.2 Europe Bioengineered Skin Substitutes Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bioengineered Skin Substitutes Market Size Forecast by Type
10.6.1 Allogenic
10.6.2 Autologous
10.6.3 Xenogeneic
10.6.4 Acellular
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bioengineered Skin Substitutes Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Wound Care Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bioengineered Skin Substitutes Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bioengineered Skin Substitutes Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bioengineered Skin Substitutes Market Size Forecast by Type
11.6.1 Allogenic
11.6.2 Autologous
11.6.3 Xenogeneic
11.6.4 Acellular
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bioengineered Skin Substitutes Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Wound Care Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bioengineered Skin Substitutes Analysis and Forecast
12.1 Introduction
12.2 Latin America Bioengineered Skin Substitutes Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bioengineered Skin Substitutes Market Size Forecast by Type
12.6.1 Allogenic
12.6.2 Autologous
12.6.3 Xenogeneic
12.6.4 Acellular
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bioengineered Skin Substitutes Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Wound Care Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bioengineered Skin Substitutes Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bioengineered Skin Substitutes Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bioengineered Skin Substitutes Market Size Forecast by Type
13.6.1 Allogenic
13.6.2 Autologous
13.6.3 Xenogeneic
13.6.4 Acellular
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bioengineered Skin Substitutes Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Wound Care Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioengineered Skin Substitutes Market: Competitive Dashboard
14.2 Global Bioengineered Skin Substitutes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Smith & Nephew
14.3.3 AbbVie Inc
14.3.4 Stryker Corporation
14.3.5 Anika Therapeutics Inc
14.3.6 Zimmer Biomet Holdings
14.3.7 Vericel Corporation
14.3.8 Integra LifeSciences
14.3.9 Aroa Biosurgery
14.3.10 Organogenesis Inc
14.3.11 Mölnlycke Health Care AB
14.3.12 AlloSource
14.3.13 Cook Biotech Incorporated
14.3.14 Promethean LifeSciences
14.3.15 ACell
